Swapan Khandelwal Acquires 60,000 Shares in Goldline Pharmaceutical

Swapan Khandelwal, Promoter and Whole Time Director of Goldline Pharmaceutical Limited, has acquired 60,000 equity shares through an open market purchase. The acquisition took place on June 22, 2026. Prior to this transaction, Khandelwal held 2,749,988 shares, representing 28.65% of the total paid-up capital. After the acquisition, his total holding increased to 2,809,988 shares, which constitutes 29.27% of the company's total paid-up capital. This disclosure is made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.